(Q73081089)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Martin C Peters

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

David J Mooney

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

Journal of Controlled Release

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

49-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery. Lessons from the randomized trials

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Enhanced revascularization of the ischemic limb by angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Therapeutic angiogenesis in cardiology using protein formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Blood vessel formation: what is its molecular basis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

1 reference

7 January 2021

FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

The fate of intravenously administered bFGF and the effect of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Preclinical and Clinical Studies with Recombinant Human Basic Fibroblast Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Experience with the preclinical assessment of basic fibroblast growth factor (bFGF)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Controlling collateral development: the difficult task of mimicking mother nature

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Biodegradable Polymers for Protein and Peptide Drug Delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Improving protein therapeutics with sustained-release formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Controlled and modulated release of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Release from alginate enhances the biological activity of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Hydrogels for tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Polymeric system for dual growth factor delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Alginate type and RGD density control myoblast phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

The fibroblast growth factor family: structural and biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900349-8

7 January 2021

10.1016/S0168-3659(02)00349-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12618022%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference